Diagnostics

Comprehend Systems Appoints New CEO in Response to Surging Demand for Clinical Intelligence Solutions; Enterprise Growth Expert to Scale Company and Expand Partner Ecosystem

November 20, 2017

Redwood City, Calif., November 13, 2017—Comprehend Systems, Inc., the leader in Clinical Intelligence solutions, has named Terry Cunningham CEO.  Cunningham will focus on scaling Comprehend in response to explosive customer demand for solutions that reduce time and risk in clinical trials. Cunningham will also drive expanded partner programs to help sponsors achieve faster, better clinical […]

How Digital Pathology is Revolutionizing Clinical Trials

November 16, 2017

The emergence of digital pathology presents an opportunity for central laboratories to support highly targeted therapeutics and precision medicine even further, offering many advantages to both diagnostic and clinical trials testing. This paper explains the noteworthy progress in the industry’s wider acceptance of digital pathology systems and its many benefits. There is also a related […]

Whole Slide Imaging and its potential role in clinical trials and primary diagnostics

November 16, 2017

In this episode, Dr. Matthew Turner talks about trends in Digital Pathology, and how this new research tool can benefit sponsors, CROs, and Pathologists. There is also a related white paper, entitled, “How Digital Pathology is Revolutionizing Clinical Trials,” which you can download using the link below.

BioIVT to Present Advances in Immunohistochemistry at AAPS Annual Meeting

November 8, 2017

BioIVT will also showcase its expanded research services resulting from its Qualyst Transporter Solutions and Asterand Bioscience™ acquisitions earlier this year BioIVT, a leading provider of biospecimens and related services, today announced that it will be presenting and exhibiting at the American Association of Pharmaceutical Scientists (AAPS) Annual Meeting. This conference will be held from […]

Abbott Announces FDA Clearance for its Alinity ci-series Next-generation Diagnostic Systems

November 2, 2017

ABBOTT PARK, Ill., Oct. 31, 2017 — (Healthcare Sales & Marketing Network) — Abbott (NYSE: ABT) has secured U.S. Food and Drug Administration (FDA) 510(k) clearance for its Alinity ci-series instruments for clinical chemistry and immunoassay diagnostics. These innovative testing solutions were designed to help the lab more effectively address modern industry challenges, including aging […]

BioIVT Expands Its Support for Precision Medicine Researchers

October 25, 2017

BioIVT is sponsoring the Powering Precision Health Summit 2017 and showcasing its precision medicine product and services portfolio BioIVT, a leading provider of biospecimens and related services, today announced that it is sponsoring the Powering Precision Health Summit (PPHS) 2017. This conference will bring together leaders in biomarker research and translational medicine to present the […]

Improving Time-to-Market and Clinical Quality of Studies with Video EEG Protocol

October 24, 2017

Drug development costs for Central Nervous System (CNS) trials are more complex and costly for pharmaceutical companies and often take longer to develop than other medicines. Failed studies often occur later in development when costs are the highest. For compound efficacy and safety that is being measured with electroencephalography (EEG), technical and recording difficulties simply […]

Laboratory Informatics Leaders to Gather in Philadelphia

October 24, 2017

Philadelphia, PA  (October 20)  IQPC’s  14th Laboratory Informatics Summit, the nation’s foremost event addressing innovative solutions to leverage the modern lab will take place in Philadelphia, PA, this December 4-6, 2017. This summit will focus on key themes at the forefront of news today, such as leveraging the latest in machine learning to prepare for […]

Queen’s University Belfast in Collaboration with Almac Group Lead Largest Study of its Kind to Transform Prostate Cancer Treatment

October 24, 2017

Queen’s University Belfast have led the world’s largest research study using a diagnostic test developed by Almac Diagnostics, to better understand the biology of prostate cancer tumours, which could lead to a transformation in how prostate cancer is diagnosed and treated. Whether a prostate cancer patient has a slow-growing or aggressive tumour will affect the […]

Demand for genetic testing drives growth for award winning Elucigene diagnostics

September 18, 2017

Having the right technology at the right time has made Elucigene Diagnostics a world leading developer and distributor of prenatal, rare disease and infertility genetics diagnostics. The Manchester-based company has been selected as the winner of the Venture-backed Management Team 2017 award for the Northwest in the prestigious British Private Equity & Venture Capital Association […]

Qlucore launches Omics Explorer 3.3

September 13, 2017

Qlucore, a leader in the development of bioinformatics visualization software, has today launched the latest version of its advanced data analysis software. Qlucore Omics Explorer 3.3 includes a new Next Generation Sequencing (NGS) Module and additional new functionalities. Qlucore Omics Explorer is a next-generation bioinformatics software program for broad usage, known for its easy to […]

FEEDBACK